Frequently, drug development has focused on minute molecules, but amino acid alliances are rapidly receiving attention. This new strategy utilizes combining short amino acid chains with complementary therapeutic modalities to address challenging disease targets. By leveraging the specific properties of amino acid sequences – such as high precisio